Authors: Dr Brendan Nolan and Dr Sav Zwickl.
Content Warning: Mention of depression, gender dysphoria and suicidality.
Trans Health Research recently published findings from our study on the impact of fast access to testosterone gender-affirming hormone therapy (GAHT) on mental health and wellbeing in the peer-reviewed journal, JAMA Network Open.
Reandron testosterone, which was used in this study. Credit: Steve Tritton via Shutterstock.
Results showed significant reductions in gender dysphoria, depression, and suicidality after 3 months with early testosterone GAHT use compared to standard care. Remarkably, over half of the study participants receiving testosterone experienced resolution of "thoughts of hurting themselves or that they were better off dead".